©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 114535
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.114535
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.114535
Table 1 Innervation of key metabolic organs and their roles in blood glucose regulation
| Organ | Nerve type | Innervation description | Role in glucose regulation | Key neurotransmitters/pathways |
| Liver | SNS | Predominantly innervated by the greater splanchnic nerve | Activation stimulates hepatic glycogenolysis and gluconeogenesis, thereby increasing hepatic glucose output | Primarily releases norepinephrine, which acts on α- and β-adrenergic receptors |
| PSNS | Innervated by the hepatic branch of the vagus nerve | Activation promotes glycogen synthesis and suppresses gluconeogenesis, leading to reduced hepatic glucose output | Releases acetylcholine, acting primarily on M3 muscarinic receptors | |
| Sensory nerves | Express various metabosensors | Detect intrahepatic signals such as glucose levels, ATP/AMP ratio, and inflammatory cytokines, and relay this information to the brainstem and hypothalamus | / | |
| Pancreas | SNS | Originates from the celiac ganglion | Activation inhibits insulin secretion from β-cells while stimulating glucagon release from α-cells | Releases norepinephrine, which acts on α2-adrenergic receptors to suppress insulin secretion |
| PSNS | Derived from the pancreatic branch of the vagus nerve | Activation (particularly postprandially) strongly stimulates the secretion of both insulin and glucagon, exhibiting a biphasic effect | Primarily releases acetylcholine acting on M3 receptors, promoting insulin secretion via the IP3/PKC signaling pathway. Additionally, neuropeptides such as VIP and PACAP are involved in enhancing secretory responses | |
| Sensory nerves | Densely distributed throughout the islets of Langerhans and surrounding pancreatic tissue | Detect local insulin and glucose levels, and participate in the feedback regulation of pancreatic islet function | / | |
| Adipose tissue | SNS | Heavily innervates both white and brown adipose tissue | Activation stimulates lipolysis, increasing the release of FFAs, which may indirectly affect hepatic glucose output and muscle glucose utilization via lipotoxicity | Releases norepinephrine, which primarily acts on β3-adrenergic receptors to promote lipolysis |
| Sensory nerves | Provide feedback on adipose tissue metabolic status | Detect levels of adipokines such as leptin and adiponectin, and relay energy storage signals to the central nervous system | Express receptors such as LepR and TrkB, the latter being a high-affinity receptor for BDNF | |
| Skeletal muscle | SNS | Innervates blood vessels and muscle fibers | Moderate activation induces vasoconstriction, thereby limiting glucose delivery; excessive activation indirectly suppresses glucose uptake via β-AR-mediated mechanisms | Releases norepinephrine, which acts on α1-adrenergic receptors (causing vasoconstriction) and β2-adrenergic receptors (promoting vasodilation and enhancing glucose uptake). Key mechanisms in contraction-induced |
| Somatic motor nerves | Regulate voluntary muscle contraction | Muscle contraction per se serves as the most potent stimulus for glucose uptake and utilization, primarily through AMPK activation and enhanced GLUT4 translocation | / | |
| Gastrointestinal tract | PSNS | Vagus nerve (afferent/efferent) SNS | Enhances intestinal motility, stimulates secretion, and increases nutrient absorption surface area, thereby indirectly modulating the rate of blood glucose elevation | / |
| Sensory nerves | Extremely abundant | Play an essential role. They detect nutrients such as glucose, fatty acids, and amino acids, as well as hormones (e.g., GLP-1, PYY, CCK), and transmit these signals via vagal afferents to the NTS. This triggers gut-brain axis reflexes that preemptively regulate insulin secretion (cephalic phase insulin release) and promote satiety | Express a wide range of nutrient-sensing receptors, including but not limited to GLP-1R, CCKAR, SGLT1, and GPR40 |
- Citation: Wang SY, Liu X, Li ZM, Deng CX, Chen KR, Zhuang SY, Xu B, Xu TC. Peripheral nerve-mediated glucose lowering: Mechanisms, translational strategies, and future perspectives. World J Diabetes 2026; 17(1): 114535
- URL: https://www.wjgnet.com/1948-9358/full/v17/i1/114535.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i1.114535